BOLD vs DKNG · P/E 0.1, $24.6M cap vs rev $4.77B
Boundless Bio, Inc. Common Stock (BOLD) versus DraftKings Inc (DKNG) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
DraftKings Inc (DKNG) is a gambling company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported DKNG revenue for 2024-12-31 was $4.77B. Net income was -$507.3M. Revenue was up 30.1% from 2023-12-31 to 2024-12-31. DKNG currently screens at market cap $20.96B.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. DKNG currently screens at market cap $20.96B.
Not investment advice. Open the BOLD and DKNG stock pages for the full models.
Not investment advice.